The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126078215 12607821 5 F 2008 20160915 20160729 20160916 EXP US-JNJFOC-20090304320 JANSSEN 0.00 A M Y 116.58000 KG 20160916 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126078215 12607821 1 SS RISPERDAL RISPERIDONE 1 Oral N N UNKNOWN;UNKNOWN 0 6 MG TABLETS
126078215 12607821 2 PS RISPERDAL RISPERIDONE 1 Oral 1 MG TO 3 MG N N UNKNOWN;UNKNOWN 20272 3 MG TABLETS QD
126078215 12607821 3 SS RISPERDAL CONSTA RISPERIDONE 1 Intramuscular N N UNKNOWN 21346 50 MG MICROSPHERES QOW
126078215 12607821 4 SS INVEGA SUSTENNA PALIPERIDONE PALMITATE 1 Intramuscular INITIAL DOSE FOLLOWED BY 2 INJECTIONS OF 156 MG N N UNKNOWN 22264 INJECTION
126078215 12607821 5 SS INVEGA PALIPERIDONE 1 Oral N N UNKNOWN 21999 TABLETS
126078215 12607821 6 SS HALOPERIDOL. HALOPERIDOL 1 Unknown N UNKNOWN 15923 UNSPECIFIED
126078215 12607821 7 SS SEROQUEL QUETIAPINE FUMARATE 1 Oral 50 MG TO 200 MG U 0 TABLETS
126078215 12607821 8 C LEXAPRO ESCITALOPRAM OXALATE 1 Oral D 0 20 MG UNSPECIFIED QD
126078215 12607821 9 C TOPAMAX TOPIRAMATE 1 Unknown D 0 UNSPECIFIED
126078215 12607821 10 C VITAMIN VITAMINS 1 Unknown D 0 UNSPECIFIED
126078215 12607821 11 C TRILEPTAL OXCARBAZEPINE 1 Unknown D 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126078215 12607821 1 Schizoaffective disorder
126078215 12607821 2 Schizoaffective disorder
126078215 12607821 3 Schizoaffective disorder
126078215 12607821 4 Schizoaffective disorder
126078215 12607821 5 Schizoaffective disorder
126078215 12607821 6 Schizoaffective disorder
126078215 12607821 7 Schizophrenia
126078215 12607821 8 Depression
126078215 12607821 9 Drug therapy
126078215 12607821 10 Vitamin supplementation

Outcome of event

Event ID CASEID OUTC COD
126078215 12607821 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126078215 12607821 Blood cholesterol increased
126078215 12607821 Drug effect decreased
126078215 12607821 Drug ineffective
126078215 12607821 Drug intolerance
126078215 12607821 Hyperphagia
126078215 12607821 Psychotic disorder
126078215 12607821 Schizoaffective disorder
126078215 12607821 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126078215 12607821 1 200805 0
126078215 12607821 2 200805 0
126078215 12607821 3 200805 0
126078215 12607821 4 20160601 201607 0
126078215 12607821 5 201605 201607 0
126078215 12607821 6 201607 0
126078215 12607821 7 200805 0
126078215 12607821 8 200805 0
126078215 12607821 9 2004 0